CHRONOS-3: Randomized Phase III study of copanlisib plus rituximab vs rituximab/placebo in relapsed indolent non-Hodgkin lymphoma (iNHL).


Matasar M. J., Capra M., ÖZCAN M., Lv F., Li W., Yanez E., ...Daha Fazla

CANCER RESEARCH, cilt.81, sa.13, 2021 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 81 Sayı: 13
  • Basım Tarihi: 2021
  • Dergi Adı: CANCER RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, BIOSIS, Biotechnology Research Abstracts, CAB Abstracts, Chemical Abstracts Core, EMBASE, Gender Studies Database, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
  • Ankara Üniversitesi Adresli: Evet